PAARX
Price
$17.20
Change
+$0.04 (+0.23%)
Updated
Oct 17 closing price
Net Assets
2.33B
RLBEX
Price
$38.94
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.62B
Interact to see
Advertisement

PAARX vs RLBEX

Header iconPAARX vs RLBEX Comparison
Open Charts PAARX vs RLBEXBanner chart's image
Putnam Dynamic Asset Allocation Bal R
Price$17.20
Change+$0.04 (+0.23%)
VolumeN/A
Net Assets2.33B
American Funds American Balanced R4
Price$38.94
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.62B
PAARX vs RLBEX Comparison Chart in %
View a ticker or compare two or three
VS
PAARX vs. RLBEX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAARX is a Hold and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 266B vs. PAARX (2.33B). PAARX pays higher dividends than RLBEX: PAARX (2.35) vs RLBEX (1.74). PAARX was incepted earlier than RLBEX: PAARX (23 years) vs RLBEX (23 years). PAARX (1.18) is less costly to investors than RLBEX (0.59). PAARX is a more actively managed with annual turnover of: 222.00 vs. RLBEX (44.00). PAARX has a lower initial minimum investment than RLBEX: PAARX (0) vs RLBEX (250). RLBEX annual gain was more profitable for investors over the last year : 8.70 vs. PAARX (1.98). RLBEX return over 5 years is better than : 42.04 vs. PAARX (18.79).
PAARXRLBEXPAARX / RLBEX
Total Expense Ratio1.180.59200%
Annual Report Gross Expense Ratio1.180.59200%
Fund Existence23 years23 years-
Gain YTD11.74514.63180%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.33B266B1%
Annual Yield % from dividends2.351.74135%
Returns for 1 year1.988.7023%
Returns for 3 years35.4750.5270%
Returns for 5 years18.7942.0445%
Returns for 10 years37.1077.6948%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP15.380.38
+2.53%
Coeptis Therapeutics Holdings Inc
DHT12.110.23
+1.94%
DHT Holdings
PTLO5.900.02
+0.34%
Portillo's
ATMVU22.00N/A
N/A
AlphaVest Acquisition Corp
BBIO54.92-0.11
-0.20%
BridgeBio Pharma